Citations 1
Safety and Feasibility of Reduced-Frequency Dosing of Axatilimab in Patients Treated in the AGAVE-201 Study
Farhadfar, Nosha , Soto, Maria Sola, Chhabra, Saurabh , Bhatt, Valkal, Andersen, Emily Helen, Xue, Zhenyi , DeFilipp, Zachariah
Blood Advances | October 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
